New at Prodigy Blog A collection of articles about our people, our capabilities, our industry, and everything in between. Del Doherty 6/19/25 Del Doherty 6/19/25 Cardiovascular Diseases Part 2 of 2: New Frontiers in CVD Treatment (2020–2025) Read More Del Doherty 6/12/25 Del Doherty 6/12/25 Cardiovascular Disease Claims in Workers’ Comp (Part 1 of 2) Read More Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More Del Doherty 6/6/25 Del Doherty 6/6/25 GLP-1s: What They Are, What They Do, and Where They Fit in Workers’ Comp Read More Del Doherty 4/30/25 Del Doherty 4/30/25 The Pill to Pay: Why Medication Adherence is the Hidden Lever in Workers’ Comp Recovery Read More Del Doherty 4/16/25 Del Doherty 4/16/25 Bunny Trail to the Top 10: Q1 2025 Drug & Therapy Classes Read More Newer Posts Older Posts
Del Doherty 6/19/25 Del Doherty 6/19/25 Cardiovascular Diseases Part 2 of 2: New Frontiers in CVD Treatment (2020–2025) Read More
Del Doherty 6/12/25 Del Doherty 6/12/25 Cardiovascular Disease Claims in Workers’ Comp (Part 1 of 2) Read More
Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More
Del Doherty 6/6/25 Del Doherty 6/6/25 GLP-1s: What They Are, What They Do, and Where They Fit in Workers’ Comp Read More
Del Doherty 4/30/25 Del Doherty 4/30/25 The Pill to Pay: Why Medication Adherence is the Hidden Lever in Workers’ Comp Recovery Read More
Del Doherty 4/16/25 Del Doherty 4/16/25 Bunny Trail to the Top 10: Q1 2025 Drug & Therapy Classes Read More